Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
3.890
+0.150 (4.01%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Sight Sciences Revenue
In the year 2025, Sight Sciences had annual revenue of $77.36M, down -3.13%. Sight Sciences had revenue of $20.39M in the quarter ending December 31, 2025, with 6.87% growth.
Revenue (ttm)
$77.36M
Revenue Growth
-3.13%
P/S Ratio
2.72
Revenue / Employee
$415,930
Employees
186
Market Cap
210.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.36M | -2.50M | -3.13% |
| Dec 31, 2024 | 79.87M | -1.19M | -1.47% |
| Dec 31, 2023 | 81.06M | 9.73M | 13.63% |
| Dec 31, 2022 | 71.33M | 22.38M | 45.70% |
| Dec 31, 2021 | 48.96M | 21.32M | 77.12% |
| Dec 31, 2020 | 27.64M | 4.29M | 18.38% |
| Dec 31, 2019 | 23.35M | 15.82M | 210.07% |
| Dec 31, 2018 | 7.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InfuSystem Holdings | 143.44M |
| Quanterix | 138.90M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| 908 Devices | 56.20M |
| SANUWAVE Health | 41.28M |
| Profound Medical | 16.10M |
| CapsoVision | 13.09M |
SGHT News
- 11 days ago - Sight Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 13 days ago - Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance - GlobeNewsWire
- 27 days ago - Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 2 months ago - Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights - GlobeNewsWire
- 2 months ago - Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge - Seeking Alpha
- 4 months ago - Sight Sciences, Inc. (SGHT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance - GlobeNewsWire